Recombinant TNF alpha (Humicade Biosimilar) antibody
Quick Overview for Recombinant TNF alpha (Humicade Biosimilar) antibody (ABIN7487761)
Target
Antibody Type
Reactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Purpose
- Anti-TNF alpha [CDP 571 (Humicade)], Mouse IgG1, kappa
-
Specificity
- The antibody binds to human TNF-alpha with a Kd of 0.087 nM.
-
Characteristics
-
Original Species of Ab: Human
Original Format of Ab: IgG4
-
Purification
- Protein A affinity purified
-
Immunogen
- Human TNF-alpha
-
Isotype
- IgG1 kappa
-
-
-
-
Application Notes
- The antibody binds specifically to TNF-alpha, a pro-inflammatory cytokine which stimulates release of other cytiokines e.g. IL-1, IL-6 and GM-CSF as well as secretion of ICAM-1 and VCAM-1 from endothelial cells. It stimulates acute phase responses and acts as a chemoattractant for NK cells and monocytes/macrophages. The antibody reached Phase II clinical trials with Celltech, UCB.
-
Comment
-
NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques.
-
Restrictions
- For Research Use only
-
-
-
Concentration
- 1 mg/mL
-
Buffer
- PBS with 0.02 % Proclin 300.
-
Preservative
- ProClin
-
Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- Store at 4°C for up to 3 months. For longer storage, aliquot and store at -20°C.
-
-
- TNF alpha (Humicade Biosimilar)
-
Target Type
- Biosimilar
-
Background
- TNFA, Tumour necrosis factor superfamily member 2, TNFSF2
-
UniProt
- P01375
Target
-